Standard Biotools (LAB) Net Shares Issued and Repurchased (2012 - 2026)

Standard Biotools (LAB) has reported Net Shares Issued and Repurchased for 6 consecutive years, with $1.0 million the latest figure, recorded in Q1 2026.

• On a quarterly basis, Net Shares Issued and Repurchased fell 82.4% year-over-year to $1.0 million in Q1 2026; TTM through Mar 2026 was $1.0 million, a 82.4% decrease from a year earlier, with the FY2025 full-year figure at $11.4 million, up 167.72% from the prior year.
• Net Shares Issued and Repurchased was $1.0 million for Q1 2026 at Standard Biotools, down from $11.4 million in the prior quarter.
• Over five years, Net Shares Issued and Repurchased peaked at $11.4 million in Q4 2025 and troughed at $583.0 in Q1 2024.
• A 4-year average of $4.0 million and a median of $2.7 million in 2023 frame the typical range for Net Shares Issued and Repurchased.
• Across the five-year window, Net Shares Issued and Repurchased soared 1013622.13% in 2025 and sank 82.4% in 2026, its largest moves.
• Over 4 years, Net Shares Issued and Repurchased stood at $1.2 million in 2023, then jumped by 268.34% to $4.2 million in 2024, then jumped by 167.72% to $11.4 million in 2025, then tumbled by 90.85% to $1.0 million in 2026.
• The last three Net Shares Issued and Repurchased figures came in at $1.0 million (Q1 2026), $11.4 million (Q4 2025), and $5.9 million (Q1 2025), per Business Quant data.